Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-15 Sale | 2024-05-17 4:24 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 69 | $430.93 | $29,734 | 49,831 (Indirect Direct) | View |
| 2024-02-26 Sale | 2024-02-27 4:37 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 5,034 | $425.7 | $2,142,974 | 49,831 (Indirect Direct) | View |
| 2024-02-21 Sale | 2024-02-23 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3,603 | $421.77 | $1,519,637 | 59,579 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-21 4:19 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,804 | $420.79 | $2,021,475 | 63,182 (Indirect Direct) | View |
| 2024-02-12 Sale | 2024-02-13 4:51 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,295 | $420.24 | $1,804,931 | 75,858 (Indirect Direct) | View |
| 2023-12-13 Sale | 2023-12-15 4:20 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 8,603 | $399 | $3,432,597 | 56,696 (Indirect Direct) | View |
| 2023-06-15 Sale | 2023-06-20 4:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 8,603 | $349 | $3,002,447 | 65,299 (Indirect Direct) | View |
| 2023-05-30 Sale | 2023-06-01 4:16 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 82 | $329.82 | $27,045 | 56,696 (Indirect Direct) | View |
| 2023-02-27 Sale | 2023-02-28 4:47 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 5,034 | $287.47 | $1,447,143 | 56,696 (Indirect Direct) | View |
| 2023-02-22 Sale | 2023-02-24 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 2,401 | $294.33 | $706,679 | 66,444 (Indirect Direct) | View |
| 2023-02-21 Sale | 2023-02-22 4:30 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 2,402 | $293.75 | $705,596 | 68,845 (Indirect Direct) | View |
| 2023-02-14 Sale | 2023-02-16 4:14 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 6,398 | $298.68 | $1,910,962 | 75,745 (Indirect Direct) | View |
| 2023-02-13 Sale | 2023-02-14 4:53 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,887 | $298.92 | $1,460,816 | 82,143 (Indirect Direct) | View |
| 2022-08-15 Sale | 2022-08-17 5:39 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 22,173 | $303.93 | $6,738,991 | 45,418 (Indirect Direct) | View |
| 2022-08-10 Sale | 2022-08-12 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 180 | $300.4 | $54,073 | 67,591 (Indirect Direct) | View |
| 2022-08-09 Sale | 2022-08-10 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 5,690 | $300.67 | $1,710,817 | 67,771 (Indirect Direct) | View |
| 2022-05-16 Sale | 2022-05-18 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 133 | $251.19 | $33,408 | 64,900 (Indirect Direct) | View |
| 2022-05-02 Sale | 2022-05-04 5:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 306 | $263.98 | $80,778 | 64,900 (Indirect Direct) | View |
| 2021-11-15 Sale | 2021-11-16 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3 | $187.26 | $562 | 41,243 (Indirect Direct) | View |
| 2021-05-17 Sale | 2021-05-19 4:04 pm | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Comm & Ops Officer | 109 | $216.41 | $23,589 | 41,243 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-21 Exercise | 2024-06-25 4:41 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 3,000 | $0 | 3,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 9:38 pm | N/A 2034-06-17 | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 4:37 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,714 | $431.79 | 49,831 (Direct) | View |
| 2024-02-20 Tax Withholding | 2024-02-21 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3,373 | $420.58 | 63,182 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,499 | $424.01 | 63,182 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 4:51 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3,177 | $422.74 | 75,858 (Direct) | View |
| 2024-02-12 Disposition | 2024-02-12 4:41 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 295,035 | $0 | 0 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 26,634 | $0 | 83,330 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 5:43 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 442 | $29.65 | 5,381 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 4:20 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 8,603 | $0 | 56,696 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 4:20 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 8,603 | $187.53 | 56,696 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-02 5:06 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 827 | $15.87 | 4,939 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 5:54 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 695 | $18.87 | 4,112 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:30 pm | N/A 2033-06-20 | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:07 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 8,603 | $0 | 65,299 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 8,603 | $187.53 | 65,299 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:47 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 32,687 | $0 | 32,687 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 4:52 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 3,417 | $3.84 | 3,417 (Direct) | View |
| 2023-02-24 Tax Withholding | 2023-02-28 4:47 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,714 | $289.12 | 56,696 (Direct) | View |
| 2023-02-17 Tax Withholding | 2023-02-22 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,498 | $292.85 | 68,845 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-14 4:53 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 5,990 | $298.26 | 82,143 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:53 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3,372 | $294.33 | 82,143 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 38,221 | $0 | 96,392 (Direct) | View |
| 2022-12-06 Option Award | 2022-12-08 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 12,753 | $0 | 58,171 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 5:39 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 6,571 | $0 | 45,418 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 5:39 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 6,571 | $155.57 | 45,418 (Direct) | View |
| 2022-08-10 Exercise | 2022-08-12 4:05 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 64 | $0 | 67,591 (Direct) | View |
| 2022-08-10 Exercise | 2022-08-12 4:05 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 64 | $155.57 | 67,591 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-10 4:06 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 1,926 | $0 | 67,771 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-10 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 1,926 | $155.57 | 67,771 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:10 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 15,000 | $0 | 107,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:10 pm | N/A 2032-06-15 | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 44,000 | $3.37 | 107,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:09 pm | N/A 2032-06-07 | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 5:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 7,246 | $227.86 | 65,206 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 4:54 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,126 | $232.51 | 72,452 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3,040 | $237.74 | 76,578 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 38,375 | $0 | 79,618 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:24 pm | N/A N/A | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 15,000 | $0 | 92,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:24 pm | N/A 2031-06-16 | ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director | 44,000 | $6.77 | 92,000 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:06 pm | N/A 2031-06-08 | RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director | 15,000 | $0 | 15,000 (Direct) | View |